| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Revenue  | 138 | 144 | 144 | 127 | 168 | 161 | 192 | 221 | 242 | 218 | 277 | 287 |
| Expenses | 129 | 132 | 138 | 138 | 158 | 150 | 169 | 193 | 203 | 186 | 218 | 231 |
| EBITDA | 9 | 13 | 6 | -11 | 11 | 11 | 24 | 29 | 40 | 32 | 59 | 56 |
| Operating Profit % | 6 % | 8 % | 4 % | -9 % | 6 % | 5 % | 10 % | 12 % | 14 % | 11 % | 19 % | 20 % |
| Depreciation | 3 | 3 | 2 | 0 | 1 | 1 | 1 | 2 | 1 | 2 | 8 | 9 |
| Interest | 5 | 5 | 3 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 |
| Profit Before Tax | 2 | 4 | 14 | -12 | 9 | 9 | 22 | 27 | 35 | 30 | 70 | 58 |
| Tax | 1 | 1 | 3 | -0 | 2 | 2 | 5 | 8 | 8 | 7 | 15 | 13 |
| Net Profit | 1 | 3 | 12 | -12 | 7 | 8 | 17 | 19 | 27 | 23 | 55 | 44 |
| EPS in ₹ | 0.45 | 1.24 | 4.53 | -4.41 | 2.75 | 3.00 | 6.51 | 7.20 | 10.20 | 3.40 | 8.26 | 6.40 |
Jagsonpal Pharmaceuticals
Jagsonpal Pharmaceuticals
202.00
+0.26
(0.13%)
Market Cap
1,351.19 Cr
PE Ratio
30.62
Volume
44,137.00
Day High - Low
206.19 - 200.50
52W High-Low
301.65 - 155.00
There are new updates from the company23 hrs ago
View
Key Fundamentals
Market Cap
1,351.19 Cr
EPS
6.40
PE Ratio
30.62
PB Ratio
4.78
Book Value
42.10
EBITDA
56.00
Dividend Yield
2.03 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
23.07
Debt to Equity
0.04
Actual
Company News
View All News
Jagsonpal Pharmaceuticals extinguished 16,00,000 equity shares on June 02, 2026. The buyback reduced share capital to ₹13,10,78,300.
Jagsonpal Buyback Concludes
9 days ago
9 days agoJagsonpal Pharmaceuticals concluded its ₹40 crore buyback, accepting 16 lakh shares at ₹250 each. The offer was subscribed 3.67 times.
Jagsonpal Pharma Independent Director ResignsMay 18, 2026
May 18, 2026Mrs. Pallavi Dinodia Gupta resigns as Independent Director of Jagsonpal Pharmaceuticals, effective May 18, 2026, citing personal and professional reasons.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,787.00 | #1 4,28,761.16 | 37.31 | #1 58,220.10 | 6.38 | #1 11,565 | 25.80 | 44.62 | |
6,565.00 | 1,74,280.12 | 67.49 | 10,560.00 | 8.73 | 2,520 | 13.44 | 44.07 | |
4,370.00 | 1,47,900.66 | 68.30 | 13,753.00 | 19.18 | 2,028 | -26.91 | 46.97 | |
1,373.20 | 1,10,924.44 | 28.84 | 27,711.70 | -2.46 | 3,783 | -55.32 | 53.76 | |
1,076.00 | 1,08,270.78 | 21.16 | 26,719.70 | 13.65 | 5,242 | 7.82 | 69.53 | |
1,261.90 | 1,05,323.60 | 25.59 | 33,593.30 | -0.44 | 3,998 | -86.05 | 43.69 | |
2,260.00 | 1,03,291.77 | #1 19.21 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 42.84 | |
2,375.00 | 98,041.20 | 48.97 | 14,277.60 | 12.03 | 1,750 | 31.75 | 42.75 | |
1,435.00 | 83,345.03 | 23.70 | 33,384.70 | 3.21 | 3,376 | 1.99 | 46.16 | |
1,394.00 | 75,256.01 | 83.88 | 6,812.90 | #1 21.03 | 884 | 21.18 | 74.67 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
3.73 %
Net Income Growth
-19.98 %
Cash Flow Change
57.24 %
ROE
92.41 %
ROCE
81.03 %
EBITDA Margin (Avg.)
-12.57 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 154 | 159 | 143 | 130 | 136 | 147 | 164 | 164 | 195 | 217 | 278 | 317 |
| Fixed Assets | 52 | 52 | 22 | 21 | 22 | 22 | 26 | 23 | 24 | 9 | 95 | 85 |
| Current Assets | 96 | 101 | 110 | 95 | 98 | 95 | 121 | 109 | 165 | 197 | 161 | 143 |
| Capital Work in Progress | 0 | 0 | 0 | 3 | 4 | 4 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 11 | 15 | 51 | 1 | 0 | 0 | 15 |
| Other Assets | 102 | 108 | 121 | 106 | 110 | 109 | 123 | 91 | 170 | 208 | 184 | 0 |
| Total Equity & Liabilities | 154 | 159 | 143 | 130 | 136 | 147 | 164 | 164 | 195 | 217 | 278 | 317 |
| Current Liabilities | 55 | 57 | 29 | 29 | 28 | 33 | 40 | 27 | 28 | 19 | 26 | 28 |
| Non Current Liabilities | 4 | 4 | 3 | 3 | 3 | 3 | 2 | 5 | 9 | 11 | 12 | 12 |
| Total Equity | 95 | 98 | 110 | 98 | 105 | 111 | 122 | 133 | 159 | 187 | 240 | 276 |
| Reserve & Surplus | 82 | 85 | 97 | 85 | 91 | 98 | 109 | 120 | 146 | 174 | 226 | 263 |
| Share Capital | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 2 | 1 | 5 | -6 | 24 | -1 | 19 | -36 | -12 | 2 | -2 |
| Investing Activities | -1 | -2 | 41 | -3 | -1 | -11 | -2 | -26 | -58 | -25 | -45 |
| Operating Activities | 4 | 9 | -3 | -2 | 31 | 11 | 28 | 7 | 47 | 35 | 55 |
| Financing Activities | -1 | -6 | -34 | -1 | -6 | -1 | -7 | -18 | -1 | -9 | -12 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 70.34 % | 70.34 % | 70.34 % | 70.34 % | 68.71 % | 68.71 % | 68.71 % | 68.71 % | 68.71 % | 68.71 % | 68.71 % | 68.48 % | 68.09 % | 68.04 % | 67.97 % | 67.81 % | 67.78 % | 67.65 % | 67.54 % | 67.39 % | 67.89 % |
| FIIs | 0.00 % | 0.00 % | 0.11 % | 0.20 % | 0.00 % | 0.00 % | 0.13 % | 0.00 % | 0.00 % | 0.00 % | 0.38 % | 0.00 % | 0.73 % | 1.10 % | 2.30 % | 2.10 % | 2.10 % | 2.18 % | 2.12 % | 2.12 % | 2.44 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.28 % | 0.77 % | 0.83 % | 0.83 % | 0.83 % | 0.00 % | 0.85 % | 0.85 % | 0.11 % | 0.00 % | 0.00 % | 0.05 % | 0.09 % | 0.15 % | 0.22 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 26.67 % | 26.08 % | 23.71 % | 23.71 % | 22.92 % | 25.27 % | 22.78 % | 21.11 % | 22.23 % | 22.84 % | 21.99 % | 21.94 % | 20.69 % | 20.79 % | 20.38 % | 20.64 % | 20.94 % | 24.26 % | 21.13 % | 21.20 % | 20.73 % |
| Others | 2.98 % | 3.57 % | 5.83 % | 5.75 % | 8.36 % | 6.02 % | 8.10 % | 9.40 % | 8.23 % | 7.62 % | 8.09 % | 9.58 % | 9.64 % | 9.22 % | 9.24 % | 9.45 % | 9.17 % | 5.86 % | 9.12 % | 9.14 % | 8.71 % |
| No of Share Holders | 0 | 12,546 | 14,655 | 14,353 | 20,031 | 17,100 | 16,194 | 14,952 | 14,084 | 13,782 | 16,041 | 15,785 | 16,282 | 15,748 | 15,633 | 18,471 | 21,085 | 22,899 | 24,653 | 24,895 | 26,264 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.1 | 0.1 | 0.25 | 0.5 | 1 | 4 | 5 | 5 | 2.5 | 0.00 |
| Dividend Yield (%) | 0.93 | 0.95 | 3.56 | 1.57 | 0.8 | 3.45 | 4.52 | 2.3 | 1.36 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 24 Sept 2021 |  Dividend | ₹ 1.00 /share | 22 Sept 2021 | 61.54 | 61.64 |
| 01 Nov 2021 | Dividend | ₹ 4.00 /share | 29 Oct 2021 | 64.98 | 69.88 |
| 17 Jun 2022 |  Extraordinary General Meeting | NA | 17 Jun 2022 | 118.24 | 111.40 |
| 21 Aug 2023 | Dividend | ₹ 5.00 /share | 21 Aug 2023 | 141.58 | 183.34 |
| 06 Sept 2024 | Dividend | ₹ 5.00 /share | 06 Sept 2024 | 144.42 | 167.08 |
| 18 Sept 2024 |  Annual General Meeting | NA | 18 Sept 2024 | 144.54 | 164.02 |
| 23 Oct 2024 |  Quarterly Result Announcement | NA | 23 Oct 2024 | 181.68 | 183.76 |
| 23 Oct 2024 |  Split | 2:5 | 08 Jan 2025 | 183.76 | 183.76 |
| 22 Jan 2025 | Quarterly Result Announcement | NA | 22 Jan 2025 | 215.25 | 222.00 |
| 06 May 2025 | Quarterly Result Announcement | NA | 06 May 2025 | 232.50 | 250.05 |
| 26 Jul 2025 | Quarterly Result Announcement | NA | 26 Jul 2025 | 262.50 | 263.29 |
| 12 Sept 2025 | Dividend | ₹ 2.50 /share | 12 Sept 2025 | 250.05 | 247.82 |
| 24 Sept 2025 | Annual General Meeting | NA | 24 Sept 2025 | 263.29 | 241.89 |
| 03 Nov 2025 | Quarterly Result Announcement | NA | 03 Nov 2025 | 216.10 | 222.84 |
| 21 Jan 2026 | Quarterly Result Announcement | NA | 21 Jan 2026 | 179.00 | 172.17 |
| 27 Apr 2026 | Quarterly Result Announcement | NA | 27 Apr 2026 | 191.94 | 199.45 |
| 08 May 2026 |  Buyback | 250 | 04 May 2026 | 210.05 | 213.35 |
Announcements
Announcement under Regulation 30 (LODR)-Closure of Buy Back23 hrs ago
23 hrs agoCompliances-Reg.24(A)-Annual Secretarial Compliance6 days ago
6 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication9 days ago
9 days agoPost Buyback Public Announcement9 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-Resignation of DirectorMay 18, 2026
May 18, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 07, 2026
May 07, 2026Submission Of Letter Of Offer For Buy-Back Upto 1600000 Equity SharesMay 06, 2026
May 06, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 04, 2026
May 04, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 29, 2026
Apr 29, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 29, 2026
Apr 29, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeApr 28, 2026
Apr 28, 2026Corporate Action-Board approves DividendApr 27, 2026
Apr 27, 2026Intimation Of Record Date For The Purpose Of Buy-Back Of Up To 1600000 Fully Paid-Up Equity Shares Of
Face Value ?2/- Each At A Price Of ?250/- Per Share For An Aggregate Amount Not Exceeding ?40 CroresApr 27, 2026
Apr 27, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSApr 27, 2026
Apr 27, 2026Announcement under Regulation 30 (LODR)-Investor PresentationApr 27, 2026
Apr 27, 2026Corporate Action-Board to consider DividendApr 27, 2026
Apr 27, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 27, 2026
Apr 27, 2026Audited Financial Results For The Year Ended March 31 2026Apr 27, 2026
Apr 27, 2026Board Meeting Outcome for Outcome Of Board MeetingApr 27, 2026
Apr 27, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 27, 2026
Apr 27, 2026 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 27, 2026
Apr 27, 2026Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotApr 27, 2026
Apr 27, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 22, 2026
Apr 22, 2026Board Meeting Intimation for Prior Intimation Of Board Meeting
Apr 20, 2026
Apr 20, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 14, 2026
Apr 14, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSApr 13, 2026
Apr 13, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2026
Apr 10, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 26, 2026
Mar 26, 2026Closure of Trading WindowMar 26, 2026
Mar 26, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 25, 2026
Mar 25, 2026Announcement Under Regulation 30 Of Sebi LODRMar 13, 2026
Mar 13, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 12, 2026
Mar 12, 2026Board Meeting Outcome for Outcome Of Board MeetingMar 12, 2026
Mar 12, 2026Board Meeting Intimation for Proposal Of Buyback Of Equity Shares Of The CompanyMar 09, 2026
Mar 09, 2026Announcement Under Regulation 30 Of SEBI LODRMar 09, 2026
Mar 09, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMar 09, 2026
Mar 09, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMar 09, 2026
Mar 09, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJan 27, 2026
Jan 27, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 22, 2026
Jan 22, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 22, 2026
Jan 22, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 21, 2026
Jan 21, 2026Announcement under Regulation 30 (LODR)-Investor PresentationJan 21, 2026
Jan 21, 2026Outcome Of Board Meeting Held On January 21 2026 Along With Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Jan 21, 2026
Jan 21, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On January 21 2026 Along With Unaudited Financial Results For The
Quarter And Nine Months Ended December 31 2025Jan 21, 2026
Jan 21, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 15, 2026
Jan 15, 2026Board Meeting Intimation for Intimation Of Board MeetingJan 13, 2026
Jan 13, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Jan 06, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJan 06, 2026
Jan 06, 2026Announcement Under Regulation 30 Of SEBI (LODR) 2015Dec 30, 2025
Dec 30, 2025Closure of Trading WindowDec 26, 2025
Dec 26, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.03% | 0 | 0.00% | 0.00% |
Technical Indicators
RSI(14)
Neutral 47.39
ATR(14)
Less Volatile 8.33
STOCH(9,6)
Neutral 55.62
STOCH RSI(14)
Neutral 28.69
MACD(12,26)
Bearish -1.25
ADX(14)
Weak Trend 23.93
UO(9)
Bearish 40.81
ROC(12)
Downtrend And Accelerating -2.67
WillR(14)
Neutral -63.32
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
